Table.

Literature of SARS-CoV-2 and influenza A co-infection case reports

Country and month/year	Number of cases	Age (yr/gender)	Comorbid conditions	Abnormal laboratory parameters	Radiological findings	Treatment	Outcome
Wuhan, China, January 202015	One	69, male	None	Leucopenia and lymphopenia	CT scan report - Mass, ground-glass consolidation in the right inferior lobe of the lungs	Oral oseltamivir ICU - Endotracheal intubation	Transferred
Tokyo, Japan, February 202016	One	78, female	Dyslipidaemia, hypothyroidism	Elevated liver enzymes	CT scan report - Ground- glass opacity adjacent to pleura Chest X-rays - Bilateral reticular shadow	Oral oseltamivir	Discharged
Barcelona, Spain, 202017	Three	53, male (P1) 78, male (P2) 56, male (P3)	All patients had hypertension P1 - End-stage renal disease (on dialysis) P2 - Type 2 diabetes mellitus	P1 - Elevated CRP. Ferritin, D-dimer P2 - Elevated CRP, LDH, D-dimer P3 - Elevated CRP, LDH, D-dimer	Chest X-rays - P2 - Bilateral infiltrate	P1, P2 - Mechanical ventilation Lopinavir-ritonavir 400/100 mg twice a day, oral HCQ 200 mg twice a day (in haemodialysis patients, 100 mg twice a day) and oral oseltamivir 150 mg twice a day (in haemodialysis patients, 30 mg every 48 h). Subcutaneous interferon β-1b 8 MU was added every 48 h in P2	P3 - Discharged after 48 h
Rome, Italy, March 202018	One	56, male	Overweight, history of myocardial infarction	Lymphopenia, CRP, fibrinogen elevated	CT scan report - Bilateral peripheral ground-glass opacities	ICU - Non-invasive ventilation Oral oseltamivir (75 mg twice per day for five days) and lopinavir/ritonavir (400/100 mg twice per day for 14 days) Intravenous methylprednisolone (40 mg twice daily for five days with tapered discontinuation)	Discharged
Kentucky, USA, 202013	One	66, female	Hypertension, diabetes, chronic kidney disease Stage 3, congestive heart failure, coronary artery disease	-	Chest X-ray - Right lower lobe infiltrate	ICU - Ventilated Oral Tamiflu® 30 mg twice a day for five days HCQ	Not mentioned
Istanbul, Turkey, March-May, 202019	Two	P1-49, female P2-51, male	P2 - Diabetes mellitus	P2 - Ferritin elevated	CT scan report - Bilateral peripheral ground-glass opacities	HCQ, azithromycin, oseltamivir	Discharged
Wuhan, China, September, 202020	Three	P1-47, female P2-50, male P3-49, female	P2 - Hypertension	P1 and P2 - Lymphopenia CRP elevated in P1, P2 and P3	CT scan report - Pulmonary lesions	Oral oseltamivir Glucocorticoid therapy P2 - Non-invasive ventilation	Discharged
Bojnurd, Iran, March-April, 202012	Two	P1-78, female P2-75, male	P1 - Chronic lung disease	P1 and P2 - Lymphopenia	CT scan report - Bilateral peripheral ground-glass opacities	ICU Combination HCQ and Kaletra® (lopinavir/ritonavir)	P1 and P2 expired

CRP, C-reactive protein; CT, computed tomography; ICU, intensive care unit; HCQ, hydroxychloroquine; LDH, lactate dehydrogenase